首页> 外文期刊>BMC Veterinary Research >Evaluation of the effect of calcium gluconate and bovine thrombin on the temporal release of transforming growth factor beta 1 and platelet-derived growth factor isoform BB from feline platelet concentrates
【24h】

Evaluation of the effect of calcium gluconate and bovine thrombin on the temporal release of transforming growth factor beta 1 and platelet-derived growth factor isoform BB from feline platelet concentrates

机译:评价葡萄糖酸钙和牛凝血酶对猫血小板浓缩液中转化生长因子β1和血小板衍生的生长因子同工型BB的暂时释放的影响

获取原文
       

摘要

Background There are not reported regarding the protocols for obtaining platelet concentrates (PC) in cats for medical purposes. The objectives of this study were: 1) to describe a manual method for producing two kinds of PC in cats (PC-A and PC-B), 2) to describe the cellular population of the PC, 3) to measure and compare the effect of calcium gluconate (CG) and bovine thrombin (BT) on the temporal release of transforming growth factor beta 1 (TGF-β1) and platelet-derived growth factor type BB (PDGF-BB) at 3 and 12 hours post-activation and 4) to establish correlations between the cellular population of both PCs and the concentration of growth factors (GF). Blood samples were taken from 16 cats for complete blood count, plasma collection and PC preparation. The PC were arbitrarily divided into two fractions, specifically, PC-A (lower fraction) and PC-B (upper fraction). Results The platelet counts were significantly different (P1 concentration efficiencies for PC-A and PC-B activated with CG were 42.86% and 46.54%, and activated with BT were 42.88% and 54.64%, respectively. The PDGF-BB concentration efficiencies for PC-A and PC-B activated with CG were 61.36% and 60.61%, and activated with BT were 65.64% and 72.12%, respectively. The temporal release of GFs showed no statistically significant difference (P>0.05) between the activating substances at the time or for any PC fraction. Conclusions Whatever the activation means, these preparations of cat PC provide significant concentrations of platelets and GFs for possible clinical or experimental use.
机译:背景技术尚未报道用于在猫中获得用于医学目的的血小板浓缩物(PC)的方案。这项研究的目的是:1)描述在猫中生产两种PC(PC-A和PC-B)的手动方法,2)描述PC的细胞数量,3)测量和比较酸钙(CG)和牛凝血酶(BT)对转化生长因子β1(TGF-β 1 )和血小板源性生长因子BB型(PDGF-BB)的瞬时释放的影响激活后3和12小时,以及4)建立两个PC的细胞数量与生长因子(GF)浓度之间的相关性。从16只猫中采集血样进行全血细胞计数,血浆收集和PC制备。 PC被任意地分成两个部分,具体地,PC-A(下部部分)和PC-B(上部部分)。结果血小板计数存在显着差异(CG激活的PC-A和PC-B的P1浓度效率分别为42.86%和46.54%,BT激活的P1浓度效率分别为42.88%和54.64%。 CG活化的PC-A和PC-B的浓度效率分别为61.36%和60.61%,BT活化的PC-B的效率分别为65.64%和72.12%。结论无论采用何种活化手段,这些cat PC制剂均提供了高浓度的血小板和GF,可用于临床或实验用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号